Pharmacokinetic‐pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus

Documenti analoghi

• Exposure–response modeling for nausea incidence for cotadutide using a Markov modeling approach
  di: Hongtao Yu, et al.
  Pubblicazione: (2024)
• Pharmacokinetics and pharmacodynamics of empagliflozin in paediatric patients aged 10–17 years with type 2 diabetes mellitus
  di: Juliane Rascher, et al.
  Pubblicazione: (2025)
• The role of venous capacity in fluid retention with endothelin A antagonism: Mathematical modelling of the RADAR trial
  di: Hongtao Yu, et al.
  Pubblicazione: (2024)
• Pharmacokinetic‐pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real‐world data
  di: Charlotte M. Thomas, et al.
  Pubblicazione: (2026)
• Pharmacokinetics and pharmacodynamics of intranasal insulin in a rat brain
  di: Jelena Osmanovic Barilar, et al.
  Pubblicazione: (2025)